Exercise training and COVID-19: a randomized controlled trial
Not Applicable
- Conditions
- COVID-19.COVID-19 diseaseU07.1
- Registration Number
- IRCT20160605028270N3
- Lead Sponsor
- Allameh Tabataba’i University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 900
Inclusion Criteria
laboratory-confirmed COVID-19 patients.
Tendency and ability to participate in exercise protocols.
Exclusion Criteria
Physically active subjects.
Participants with a history of using cigarettes and alcohol in the last 6 months.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tissue biomarkers including blood, saliva, semen, and urine. Timepoint: Baseline, weeks 4, 8, 12, 16, and one month of detraining. Method of measurement: White blood cells, neutrophils, and lymphocytes in blood, saliva, seminal fluid, and urine will be measured according to the standard laboratory techniques.
- Secondary Outcome Measures
Name Time Method Body composition. Timepoint: Baseline, weeks 4, 8, 12, 16 and 1 month of detraining. Method of measurement: By using Omron body composition analyzer.